Skip to main content
Log in

The protective effect of transdermal broxaterol on exercise-induced bronchoconstriction

  • Letter to the Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Rampulla C, Corsico R, Majani U, Lodola E (1985) Broxaterol: a double-blind clinical trial comparing broxaterol and salbutamol. Respiration 47: 299–302

    Google Scholar 

  2. Robuschi M, Damonte C, Fasano W, Bianco S, Pasargiklian M (1985) Protective effect of a new β2-agonist: 1-(3-bromo-5-isoxazolyl)-2-(tert-butylamino) ethanol hydrochloride (broxaterol hydrochloride) in bronchial constriction from inhaled distilled water mist. Curr Ther Res 37: 333–341

    Google Scholar 

  3. American Thoracic Society (1987) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 136: 225–244

    Google Scholar 

  4. Weng TR, Levison H (1969) Standards of pulmonary function in children. Am Rev Respir Dis 99: 879–894

    Google Scholar 

  5. Anderson SD, Seale JP, Rosea P, et al (1976) Inhaled and oral salbutamol in exercise-induced asthma. Am Rev Respir Dis 114: 493–500

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Robuschi, M., Scuri, M., Spagnotto, S. et al. The protective effect of transdermal broxaterol on exercise-induced bronchoconstriction. Eur J Clin Pharmacol 47, 465–466 (1995). https://doi.org/10.1007/BF00196863

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00196863

Key words

Navigation